These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma. González I; Goyal B; Xia MD; Pai RK; Ma C Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262 [TBL] [Abstract][Full Text] [Related]
6. Genomic Profiling of Small-Bowel Adenocarcinoma. Schrock AB; Devoe CE; McWilliams R; Sun J; Aparicio T; Stephens PJ; Ross JS; Wilson R; Miller VA; Ali SM; Overman MJ JAMA Oncol; 2017 Nov; 3(11):1546-1553. PubMed ID: 28617917 [TBL] [Abstract][Full Text] [Related]
8. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes. Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774 [TBL] [Abstract][Full Text] [Related]
9. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma. Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929 [TBL] [Abstract][Full Text] [Related]
10. Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma. Quaas A; Heydt C; Waldschmidt D; Alakus H; Zander T; Goeser T; Kasper P; Bruns C; Brunn A; Roth W; Hartmann N; Bunck A; Schmidt M; Buettner R; Merkelbach-Bruse S BMC Gastroenterol; 2019 Feb; 19(1):21. PubMed ID: 30717682 [TBL] [Abstract][Full Text] [Related]
11. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I-IV colorectal cancer. Guo TA; Wu YC; Tan C; Jin YT; Sheng WQ; Cai SJ; Liu FQ; Xu Y Int J Cancer; 2019 Sep; 145(6):1625-1634. PubMed ID: 31162857 [TBL] [Abstract][Full Text] [Related]
13. Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency. Xia M; Singhi AD; Dudley B; Brand R; Nikiforova M; Pai RK Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):399-406. PubMed ID: 27258561 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of mismatch repair deficiency and Lynch syndrome in a cohort of unselected small bowel adenocarcinomas. Suerink M; Kilinç G; Terlouw D; Hristova H; Sensuk L; van Egmond D; Farina Sarasqueta A; Langers AMJ; van Wezel T; Morreau H; Nielsen M; J Clin Pathol; 2021 Nov; 74(11):724-729. PubMed ID: 33046565 [TBL] [Abstract][Full Text] [Related]
15. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation. Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM Mod Pathol; 2020 Jul; 33(7):1420-1432. PubMed ID: 32047231 [TBL] [Abstract][Full Text] [Related]
16. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. Aparicio T; Henriques J; Manfredi S; Tougeron D; Bouché O; Pezet D; Piessen G; Coriat R; Zaanan A; Legoux JL; Terrebone E; Pocard M; Gornet JM; Lecomte T; Lombard-Bohas C; Perrier H; Lecaille C; Lavau-Denes S; Vernerey D; Afchain P; Int J Cancer; 2020 Aug; 147(4):967-977. PubMed ID: 31912484 [TBL] [Abstract][Full Text] [Related]
17. DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Adam L; San Lucas FA; Fowler R; Yu Y; Wu W; Liu Y; Wang H; Menter D; Tetzlaff MT; Ensor J; Manyam G; Arold ST; Huff C; Kopetz S; Scheet P; Overman MJ Clin Cancer Res; 2019 Jan; 25(2):641-651. PubMed ID: 30352910 [TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas. Wang J; Li R; He Y; Yi Y; Wu H; Liang Z Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917 [TBL] [Abstract][Full Text] [Related]
20. Small Bowel Adenocarcinoma: Is There a Difference in Survival for Crohn's Versus Sporadic Cases? Fields AC; Hu FY; Lu P; Irani J; Bleday R; Goldberg JE; Melnitchouk N J Crohns Colitis; 2020 Mar; 14(3):303-308. PubMed ID: 31541248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]